Total planned funding: $915,844,713
Clear active filters
Implementing Agency
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
South Africa | $448,828,697 |
Uganda | $78,448,596 |
Zimbabwe | $68,662,196 |
Nigeria | $64,157,129 |
Ethiopia | $45,724,456 |
Zambia | $37,463,774 |
Côte d'Ivoire | $30,445,257 |
Tanzania | $24,021,435 |
Kenya | $20,261,626 |
Mozambique | $15,205,654 |
Dominican Republic | $13,366,639 |
Malawi | $11,193,971 |
Lesotho | $10,679,374 |
Cameroon | $8,475,175 |
Guyana | $6,488,204 |
Rwanda | $5,765,000 |
Vietnam | $5,221,902 |
Ghana | $3,770,998 |
Caribbean Region | $3,517,000 |
Namibia | $3,126,607 |
Botswana | $2,953,000 |
Ukraine | $2,900,000 |
Indonesia | $1,900,000 |
Haiti | $1,806,727 |
Cambodia | $484,465 |
Russia | $470,000 |
South Sudan | $330,000 |
Angola | $150,000 |
Eswatini | $26,831 |
Asia Regional Program | $0 |
Organizational Types
Implementing Agency | $915,844,713 |
Program Areas
Treatment | $337,248,932 |
Care | $207,100,761 |
Prevention | $182,298,240 |
Governance and Systems | $84,667,946 |
Testing | $53,843,101 |
Management and Operations | $27,441 |
Budget Codes
HTXS: Treatment: Adult Treatment | $313,748,214 |
HKID: Care: Orphans and Vulnerable Children | $74,487,835 |
HVOP: Sexual Prevention: Other Sexual Prevention | $66,330,587 |
HBHC: Care: Adult Care and Support | $60,571,239 |
HVTB: Care: TB/HIV | $59,540,230 |
HVCT: Testing: HIV Testing and Counseling | $53,843,101 |
CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $47,718,937 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $42,369,449 |
OHSS: Health Systems Strengthening | $28,970,194 |
HVSI: Strategic Information | $28,321,174 |
HLAB: Laboratory Infrastructure | $27,376,578 |
PDTX: Treatment: Pediatric Treatment | $16,254,915 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $13,264,704 |
PDCS: Care: Pediatric Care and Support | $12,501,457 |
HMBL: Biomedical Prevention: Blood Safety | $10,123,254 |
HTXD: Treatment: ARV Drugs | $7,245,803 |
HMIN: Biomedical Prevention: Injection Safety | $1,971,309 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $520,000 |
HVMS: Management and Operations | $27,441 |
Top Partner Programs
University of the Witwatersrand:
$183,964,424
View countries
TB/HIV Care Association:
$90,539,118
View countries
John Snow, Inc:
$85,050,920
View countries
Caritas Internationalis:
$56,415,556
View countries